Rat basophilic leukemia cells (RBL-2H3) generate prostaglandin D2 (PGD2) after regulated upon activation, normal T-cell expressed and secreted (RANTES) activation

International Journal of Biological Markers

Volumn 21, Issue 4, 2006, Pages 211-217

  Castellani, M L ^a   Petrarca, C ^a   Frydas, S ^b   Conti, C M ^a   Salini, V ^a   Conti, P ^a   Shanmugham, L N ^c  

^a UNIVERSITY OF CHIETI   (Italy)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Chemokines; Prostaglandins; RANTES; RBL

Indexed keywords

ARACHIDONIC ACID; HISTAMINE; PROSTAGLANDIN D2; RANTES;

ANIMAL CELL; ARACHIDONIC ACID METABOLISM; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; INCUBATION TIME; INFLAMMATION; LEUKEMIA CELL LINE; MAST CELL; METABOLIC ACTIVATION; NONHUMAN; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; RAT; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

RATTUS;

EID: 33846534909     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2008.4240     Document Type: Article

References (59)

1. Conti P, Pang X, Boucher W, et al. Impact of Rantes and MCP-1 chemokines on in vivo basophilic cell recruitment in rat skin injection model and their role in modifying the protein and mRNA levels for histidine decarboxylase. Blood 1997; 89: 4120-7.
2. Morii E, Oboki K. MITF is necessary for generation of prostaglandin D2 in mouse mast cells. J Biol Chem. 2004; 279: 48923-9.
3. Marney SR Jr. Mast cell disease. Allergy Proc 1992; 13: 303-10.
4. Kielian T, McMahon M, Bearden ED, Baldwin AC, Drew PD, Esen N. S. aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Delta 12,14-prostaglandin J2 (15d-PGJ2). J Neurochem 2004; 90: 1163-72.
5. Theoharides TC, Donelan JM, Papadopoulou N, Cao J, Kempuraj D, Conti P. Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol Sci 2004; 25: 563-8.
6. Lesma E, Riva E, Giovannini M, Di Giulio AM, Gorio A. Amelioration of neutrophil membrane function underlies granulocyte-colony stimulating factor action in glycogen storage disease 1b. Int J Immunopathol Pharmacol 2005; 18: 297-308.
7. Di Giannantonio M, Frydas S, Kempuraj D, et al. Cytokines in stress. Int J Immunopathol Pharmacol 2005; 18: 1-6.
8. Alexandrakis MG, Passam FH, Pappa CA, et al. Serum evaluation of angiogenic cytokine basic fibroblast growth factor, hepatocyte growth factor and TNF-α in patients with myelodysplastic syndromes: correlation with bone marrow microvascular density. Int J Immunopathol Pharmacol 2005; 18: 287-96.
9. Trubiani O, Guarnieri S, Orciani M, Salvolini E, Di Primio R. Sphingolipid microdomains mediate CD38 internalization: Topography of the endocytosis. Int J Immunopathol Pharmacol 2004; 17: 293-300.
10. Appert-Collin A, Duong FHT, Passilly Degrace P, Warter J-M, Poindron P, Gies J-P. MAPK activation via 5-hydroxytryptamine 1A receptor is involved in the neuroprotective effects of xaliproden. Int J Immunopathol Pharmacol 2005; 18: 21-32.
11. Theoharides TC. Neuroimmunology of tumor growth: the role of mast cells. Int J Immunopathol Pharmacol 1988; 1: 89-98.
12. Kempuraj D, Madhappan B, Sheeladevi R, et al. T lymphocyte subsets and immunoglobulins in intracranial tumor patients before and after treatment, and based on histological type of tumors. Int J Immunopathol Pharmacol 2004; 17: 57-64.
13. Angeli V, Staumont D, Charbonnier AS, et al. Activation of the D prostanoid receptor 1 regulates immune and skin allergic responses. J Immunol 2004; 172: 3822-9.
14. Shrivastava P, Singh SM, Singh N. Activation of tumor-associated macrophages by thymosin alpha 1. Int J Immunopathol Pharmacol 2004; 17: 39-48.
15. Frydas S, Karagouni E, Hatzistilianou M, et al. Chemokines and allergic disorders: a revised study. Int J Immunopathol Pharmacol 2004; 17: 233-6.
16. Theoharides TC, Sant GR. A pilot open label study of Cystoprotek® in interstitial cystitis. Int J Immunopathol Pharmacol 2005; 18: 183-8.
17. Ridolo E, Albertini R, Borghi L, Meschi T, Montanari E, Dall'Aglio Pp. Acute polyradiculoneuropathy occurring after hymenoptera stings: a clinical case study. Int J Immunopathol Pharmacol 2005; 18: 385-90.
18. Totaro R, Passacantando A, Russo T, et al. Effects of interferon beta, cyclophosphamide, and azathioprine on cytokine profile in patients with multiple sclerosis. Int J Immunopathol Pharmacol 2005; 18: 377-84.
19. Demidova TN, Hamblin MR. Targeted photodynamic therapy to inflammatory cells and pathogens. Int J Immunopathol Pharmacol 2004; 17: 117-26.
20. Conti P, Reale M, Barbacane RC, Letourneau R, Theoharides TC. Intramuscular injection of hrRANTES causes mast cell recruitment and increased transcription of histidine decarboxylase in mice: lack of effect in genetically mast cell-deficient W/Wv mice. FASEB J 1998; 12: 1693-700.
21. Theoharides TC, Conti P. Mast cells: Jekyll and Hyde of tumor growth. Trends Immunol 2004; 25: 235-41.
22. Hart PH. Regulation of the inflammatory response in asthma by mast cell products. Immunol Cell Biol. 2001; 79: 149-53.
23. Sodin-Semrl S, Spagnolo A, Barbaro B, Varga J, Fiore S. Lipoxin A4 counteracts synergistic activation of human fibroblast-like synoviocytes. Int J Immunopathol Pharmacol 2004; 17: 15-25.
24. Cavalieri S, Rotoli M, Feliciani C, Amerio P. Expression of the high-affinity laminin receptor (67 kDa) in normal human skin and appendages. Int J Immunopathol Pharmacol 2005; 18: 223-32.
25. Kav AB. Mediators of hypersensitivity and inflammatory cells in the pathogenesis of bronchial asthma. Eur J Respir Dis Suppl 1983; 129: 1-44.
26. Gritti D, Malinverno A, Gasparetto C, Wiedermann CJ, Ricevuti G. Attenuation of leukocyte [beta]2-integrin expression by antithrombin-III. Int J Immunopathol Pharmacol 2004; 17: 27-32.
27. Rossi RE, Monasterolo G. A pilot study of feasibility of ultra-rush (20-25 minutes) sublingual-swallow immunotherapy in 679 patients (699 sessions) with allergic rhinitis and/or asthma. Int J Immunopathol Pharmacol 2005; 18: 277-86.
28. Kempuraj D, Huang M, Kandere-Grzybowska K, et al. Azelastine inhibits secretion of IL-6, TNF-alpha and IL-8 as well as NF-kappaB activation and intracellular calcium ion levels in normal human mast cells. Int Arch Allergy Immunol 2003; 132: 231-9.
29. Licastro F, Chiappelli M, Ruscica M, Carnelli V, Corsi MM. Altered cytokine and acute phase response protein levels in the blood of children with Downs syndrome: relationship with dementia of Alzheimer's type. Int J Immunopathol Pharmacol 2005; 18: 165-72.
30. Pannellini T, Iezzi M, Di Carlo E, et al. The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. Int J Immunopathol Pharmacol 2004; 17: 171-80.
31. Musso T, Cappello P, Stornello S, et al. IL-10 enhances CCL2 release and chemotaxis induced by CCL16 in human monocytes. Int J Immunopathol Pharmacol 2005; 18: 339-50.
32. Kempuraj D, Frydas S, Karagouni E, et al. Cytokines and the brain. Int J Immunopathol Pharmacol 2004; 17: 229-32.
33. Theoharides TC. Mast cells and stress - A psychoneuroimmunological perspective. J Clin Psychopharmacol 2002; 22: 103-8.
34. Dhabhar FS, Miller AH, McEwen BS, Spencer RL. Stress-induced changes in blood leukocyte distribution. Role of adrenal steroid hormones. J Immunol 1996; 157: 1638-44.
35. Chi DS, Fitzgerald SM, Pitts S, et al. MAPK-dependent regulation of IL-1- and beta-adrenoreceptor-induced inflammatory cytokine production from mast cells: implications for the stress response. BMC Immunol 2004; 5: 22.
36. Oppenheim JJ, Zachariae COC, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 1991; 9: 617-23.
37. Schall TJ. Biology of the RANTES/SIS cytokine family. Cytokine 1991; 3: 165-83.
38. Schuligoi R, Grill M, Heinemann A, Peskar BA, Amann R. Sequential induction of prostaglandin E and D synthases in inflammation. Biochem Biophys Res Commun 2005; 333: 684-9.
39. Hritz I, Molnár B, Tulassay Z, Prónai L. Proton pump inhibitor co-therapy normalizes the increased cell turnover of the gastric mucosa both in NSAID and selective Cox-2 users. Int J Immunopathol Pharmacol 2005; 18: 75-84.
40. Frydas S, Papaioannou N, Papazahariadou M, et al. Inhibition of MCP-1 and MIP-2 chemokines in murine trichinellosis: effect of the anti-inflammatory compound l-mimosine. Int J Immunopathol Pharmacol 2005; 18: 85-94.
41. Kempuraj D, Donelan J, Frydas S, et al. Interleukin-28 and 29 (IL-28 and IL-29): new cytokines with anti-viral activities. Int J Immunopathol Pharmacol 2004; 17: 103-6.
42. Tanaka K, Hirai H, Takano S, Nakamura M, Nagata K. Effects of prostaglandin D2 on helper T cell functions. Biochem Biophys Res Commun 2004; 316: 1009-14.
43. Marchisio M, Grimley PM, Di Baldassarre A, Santavenere E, Miscia S. Novel shift of Jak/Stat signaling characterizes the protective effects of aurintricarboxylic acid (ATA) from tumor necrosis factor-alpha toxicity in human B lymphocytes. Int J Immunopathol Pharmacol 2004; 17: 5-14.
44. Cross ML. Immune-signalling by orally-delivered probiotic bacteria: effects on common mucosal immunoresponses and protection at distal mucosal sites. Int J Immunopathol Pharmacol 2004; 17: 127-36.
45. Guidi L, Costanzo M, Ciarniello M, et al. Increased levels of NF-kB inhibitors (IκBα and IκBα) in the intestinal mucosa of Crohn's disease patients during infliximab treatment. Int J Immunopathol Pharmacol 2005; 18: 155-64.
46. Yamaki K, Uchida H, Li X, et al. Effect of varying types of anti-arthritic drugs on Th1 and Th2 immune responses in mice. Int J Immunopathol Pharmacol 2005; 18: 133-44.
47. Cognasse F, Chavarin P, Acquari S, et al. Differential downstream effects of ligation mediated by membrane or soluble CD40L and agnostic Ab: a study on purified human B cells. Int J Immunopathol Pharmacol 2005; 18: 65-74.
48. Somma P, Lo Muzio L, Mansueto G, et al. Squamous cell carcinoma of the lower lip: Fas/FasL expression, lymphocyte subtypes and outcome. Int J Immunopathol Pharmacol 2005; 18: 59-64.
49. Falkensammer B, Fasser W, Scherer K, et al. Drug monitoring and viral response to lopinavir/ritonavir or saquinavir/ritonavir containing regimens in individuals infected with the human immunodeficiency virus type 1. Int J Immunopathol Pharmacol 2005; 18: 145-54.
50. Marchisio M, Sabatino GM, Albanese A, Santavenere E, Buonaguidi R, Miscia S. Novel evidence of PLC delta2 involvement in the regulation of the differential evolution of human aneurysms. Int J Immunopathol Pharmacol 2004; 17: 381-8.
51. Centurione L, Di Giulio C, Santavenere E, et al. Protein kinase C ζ regulation of hypertrophic and apoptotic events occurring during rat neonatal heart development and growth. Int J Immunopathol Pharmacol 2005; 18: 49-58.
52. Ghezzi P, Ungheri D. Synergistic combination of n-acetyl-cysteine and ribavirin to protect from lethal influenza viral infection in a mouse model. Int J Immunopathol Pharmacol 2004; 17: 99-102.
53. Petruzzi M, De Benedittis M, Loria MP, et al. Immune response in patients with oral lichen planus and HCV infection. Int J Immunopathol Pharmacol 2004; 17: 93-8.
54. Cassano N, Loconsole F, Amoruso A, et al. Infliximab monotherapy for refractory psoriasis: preliminary results. Int J Immunopathol Pharmacol 2004; 17: 373-80.
55. Petruzzi M, De Benedittis M, Loria MP, et al. Immune response in patients with oral lichen planus and HCV infection. Int J Immunopathol Pharmacol 2004; 17: 93-8.
56. Guay J, Bateman K, Gordon R, Mancini J, Riendeau D. Carrageenan-induced paw edema in rat elicits a predominant prostaglandin E2 (PGE2) response in the central nervous system associated with the induction of microsomal PGE2 synthase-1. J Biol Chem 2004; 279: 24866-72.
57. Luo C, Simell O, Kung HF, He ML. Cox-2 expressed with insulin in pancreatic beta-cells, and in the infiltrated leukocytes in inflammed islets of diabetic mice. Eur J Inflamm 2005; 3: 55-62.
58. Ogilvic ALJ, Lüftl M, Antoni C, Schuler G, Kalden JR, Lorenz H-M. Leukocyte infiltration and mRNA expression of IL-20, IL-8 and TNF-R p60 in psoriatic ski is driven by TNF-α. Int J Immunopathol Pharmacol 2006; 19 (2): 271-8.
59. Emporiadou M, Hatzistilianou M, Haidopoulou K, et al. Procalcitonin and inflammatory cytokines in children with asthma. Eur J Inflamm 2005; 3: 75-82.